申请人:Abbott Laboratories
公开号:US08202878B2
公开(公告)日:2012-06-19
The present invention relates to a compound of formula (I), or a pharmaceutically acceptable salt thereof,
a pharmaceutical composition of formula (I), and related methods for treating or preventing metabolic diseases or conditions.
本发明涉及一种式(I)的化合物或其药学上可接受的盐,一种式(I)的药物组合物,以及相关的治疗或预防代谢性疾病或病症的方法。